Barron's

Syndicate content Barron's Features
Barron's Features
Updated: 21 weeks 3 days ago

Investing Lessons From the Activist Playbook

Thu, 03/21/2019 - 02:40
More companies are being targeted by activist investors, who are notching more victories. Yet the record on their returns is mixed.

Activist Investing Invades Europe

Wed, 03/20/2019 - 19:37
In Europe, the number of activist campaigns last year reached a record of 58, accounting for 23% of global activity, according to Lazard.

How to Invest Like an Activist

Wed, 03/20/2019 - 19:35
OK, you can’t build a significant stake in a company, and you won’t get a board seat. But you can still look at a stock as an activist would.

The Long View for Boeing Shareholders: Don't Panic

Sat, 03/16/2019 - 10:05
With just two major plane makers in the world, and booming orders, Boeing is almost certain to survive its latest crisis. But the cost could be high.

2019 Energy Roundtable: The Outlook Brightens for Oil Stocks

Sat, 03/16/2019 - 09:59
From pipeline operators to the supermajors, energy companies are gushing cash and returning it shareholders. Where to find bargains—and 7% yields.

4 Stocks That Could Rally With Steel

Sat, 03/16/2019 - 07:23
Tariffs, successful antidumping lawsuits, and Trump’s bid to jump-start U.S. manufacturing are supporting domestic steel makers.

Costco Stock Is Still Rising After Earnings and It Has Room to Grow, Analysts Say

Mon, 03/11/2019 - 21:43
Cowen analysts said that the quarter’s results alleviated their concerns about the discount retailer.

New Money Is Driving a Revival in Detroit. Can It Stick?

Sun, 03/10/2019 - 21:38
Thanks to Dan Gilbert of Quicken Loans and other investors, there is a revitalization in the downtown, and startups are flourishing. Will higher interest rates and an auto slowdown stall the momentum?

Strong Tailwinds Can Drive Delta Stock Higher

Sun, 03/10/2019 - 04:14
The shares of the best-managed airline in the U.S. trade cheaply. If Warren Buffett wants to acquire an airline, this is the one he should buy.

Offshore Oil Drillers Are in a Deep Slump. That Could Mean It's Time to Buy

Sat, 03/09/2019 - 10:03
Offshore drilling fell into a long slump as money flowed to shale projects. For contrarian investors, an offshore turnaround could have a big payoff.

Here's the Real Problem for Big Food Companies

Mon, 03/04/2019 - 00:44
Cost-cutting got the blame for the recent troubles at Kraft Heinz, but the issues with packaged food brands are much more complicated. Here’s what’s working and what’s not in the food aisle.

The Single Woman's Guide to Retirement Planning

Sat, 03/02/2019 - 10:09
The complexities of retirement planning arguably are greater for single women than married couples or widows. Here’s what to consider.

How the New Tax Law Will Affect You---and How to Lower Your Bill Next Year

Sat, 03/02/2019 - 08:59
The 2017 tax law eliminated or capped many deductions, but made up for it by doubling the standard deduction and nearly eliminating the alternative minimum tax. Will you benefit, or pay more? Here’s what to expect.

How a Diverse Workforce Can Help Company Performance

Thu, 02/28/2019 - 23:30
Corporate drives for diversity are being bolstered by an expanding body of research tying a diverse workplace to financial performance.

The Inventor of the Apple Store on Retail Revolutions--Past and Future

Thu, 02/28/2019 - 23:29
Ron Johnson played key roles at Target and Apple before stumbling at J.C. Penney. Now he’s starting anew in Silicon Valley, with some ideas about where retail is heading.

Why There's Still Plenty of Value in Apple's Core

Thu, 02/28/2019 - 23:26
A mediocre product cycle doesn’t change Apple’s strengths: a robust balance sheet, loyal customers, a stellar brand, and a sticky ecosystem of software and services.

And the Winner Is...

Thu, 02/28/2019 - 05:05
Our 18th annual forecasting challenge attracted over 4,000 entrants. The winner, Tom Kaempfer, led the pack but once again, perfection was nowhere to be seen.

Why Bristol-Myers Squibb Can Be a Sweet Pill for Investors

Thu, 02/28/2019 - 05:03
Wall Street has soured on the deal for Celgene, but Bristol-Myers has one of the lowest valuations in the drug sector and could itself become a takeover target

What I Saw at the Consumer Electronics Show

Thu, 02/28/2019 - 05:01
Smart homes and AI spoke to the future. But Delta’s biometric ID is happening now. And then there’s this year’s report on driverless cars.

The Best Stock Funds for Risky Markets

Thu, 02/28/2019 - 04:58
These funds may not shine in the headiest of bull markets, but their managers excel at picking stocks when the markets are volatile and risks abound. It’s time to give them a look.